Clinical trial
Multiinstitutional Open Label Randomized Phase II Study Comparing Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy as Firstline Treatment for Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-NHSCC)
NCT01216020 is registered in ClinicalTrials.gov with Azienda USL 4 Prato as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multiinstitutional Open Label Randomized Phase II Study Comparing Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy as Firstline Treatment for Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-NHSCC)
- Lead sponsor
- Azienda USL 4 Prato
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 31, 2010
- Completion date
- May 20, 2015
- Enrollment
- 70 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.